Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carly Rich

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Nephron|September 19, 2025
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic ReviewFernando Caravaca-Fontán, Fadi Fakhouri, Matthew C Pickering, et al.
Frontiers in Nephrology|June 8, 2026
'…completely exhausted and weak, really drained.': a multinational qualitative interview study of healthcare provider, patient, and caregiver experiences of C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis diagnosis, burden and managementSayna Norouzi, Mingyi Huang, Carly Rich, et al.
Kidney360|December 8, 2025
Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GlomerulonephritisFernando Caravaca-Fontan, Sayna Norouzi, Mingyi Huang, et al.
European Journal of Haematology|November 23, 2023
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health-related quality of life and productivityKoo Wilson, Carly Rich, Zalmai Hakimi, et al.
Advances in Therapy|May 15, 2026
Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment ComparisonsBradley P Dixon, Andrew S Bomback, Carly Rich, et al.
BMJ Open|August 23, 2013
How active are our children? Findings from the Millennium Cohort StudyLucy J Griffiths, Mario Cortina-Borja, Francesco Sera, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Nephron|September 19, 2025
Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic ReviewFernando Caravaca-Fontán, Fadi Fakhouri, Matthew C Pickering, et al.
Frontiers in Nephrology|June 8, 2026
'…completely exhausted and weak, really drained.': a multinational qualitative interview study of healthcare provider, patient, and caregiver experiences of C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis diagnosis, burden and managementSayna Norouzi, Mingyi Huang, Carly Rich, et al.
Kidney360|December 8, 2025
Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GlomerulonephritisFernando Caravaca-Fontan, Sayna Norouzi, Mingyi Huang, et al.
European Journal of Haematology|November 23, 2023
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health-related quality of life and productivityKoo Wilson, Carly Rich, Zalmai Hakimi, et al.
Advances in Therapy|May 15, 2026
Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment ComparisonsBradley P Dixon, Andrew S Bomback, Carly Rich, et al.
BMJ Open|August 23, 2013
How active are our children? Findings from the Millennium Cohort StudyLucy J Griffiths, Mario Cortina-Borja, Francesco Sera, et al.
Pageof 2